JACC: Cardiovascular Imaging
Original Research
3D Morphological Changes in LV and RV During LVAD Ramp Studies
Karima Addetia, Nir Uriel, Francesco Maffessanti, Gabriel Sayer, Sirtaz Adatya, Gene H. Kim, Nitasha Sarswat, Savitri Fedson, Diego Medvedofsky, Eric Kruse, Keith Collins, Daniel Rodgers, Takayoshi Ota, Valluvan Jeevanandam, Victor Mor-Avi, Daniel Burkhoff and Roberto M. Lang
Table 1
Table 1
Baseline Patient Characteristics
| All (N = 31) | HMII (n = 19) | HVAD (n = 12) | p Value∗ | |
|---|---|---|---|---|
| Age, yrs | 58 ± 11 | 60 ± 10 | 56 ± 13 | 0.29 |
| Male | 17 | 10 | 7 | NS |
| BSA, m2 | 2.0 ± 0.3 | 2.0 ± 0.3 | 1.8 ± 0.3 | 0.03 |
| Implant to ramp, months | 42 ± 45 | 54 ± 50 | 24 ± 26 | NS |
| Ischemic cardiomyopathy | 11 | 7 | 4 | NS |
| Diabetes | 11 | 7 | 4 | NS |
| Hypertension | 16 | 11 | 5 | NS |
| Destination therapy | 22 | 16 | 5 | NS |
| Bridge to transplant | 9 | 3 | 6 | NS |
Values are mean ± SD or n.
BSA = body surface area; HMII = HeartMate II; NS = not significant.
↵∗ p Value between HMII and HVAD groups.
Advertisement